Argentex Group agreed to a regulator's request to stop all activities following its recent liquidity issues due to market volatility.

Bridgepoint backed its full year guidance after total assets under management rose in the first half. The London-listed private-equity firm focused on the alternative investment market said pretax ...

Lupin (down 1.3%), Divis Laboratories (down 1.3%), Granules India (down 1.15%), Zydus Lifesciences (down 1.06%) and Aurobindo Pharma (down 0.94%), Sun Pharmaceutical Industries (down 0.86%), Ipca ...